What is Idexx Laboratories's cag — gross profit?

Idexx Laboratories (IDXX) reported cag — gross profit of $667.51M in Q1 2026.

How has Idexx Laboratories's cag — gross profit changed year-over-year?

Idexx Laboratories's cag — gross profit increased by 16.1% year-over-year, from $574.82M to $667.51M.

What is the long-term trend for Idexx Laboratories's cag — gross profit?

Over 3 years (2022 to 2025), Idexx Laboratories's cag — gross profit has grown at a 10.7% compound annual growth rate (CAGR), from $1.81B to $2.45B.

What does cag — gross profit mean?

The profit remaining from companion animal segment sales after subtracting the direct costs of producing those goods and services.

Business Segments · Gross Profit

CAG — Gross Profit

Idexx Laboratories CAG — Gross Profit increased by 10.5% to $667.51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $574.82M to $667.51M. Over 3 years (FY 2022 to FY 2025), CAG — Gross Profit shows an upward trend with a 10.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryProfitability

SignalHigher is better

VolatilityStable

First reportedQ1 2019

Last reportedQ1 2026

Rolls up toGross Profit

How to read this metric

An increase indicates improved pricing power or more efficient production processes, while a decrease suggests margin compression due to rising costs or competitive pricing pressure.

Detailed definition

This metric is calculated as the total revenue of the Companion Animal Group segment minus its direct cost of revenue. I...

Peer comparison

Comparable to segment-level gross profit margins reported by peers in the veterinary or human diagnostic equipment industries.

Metric ID: idxx_segment_cag_gross_profit

Historical Data

17 periods

	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$451.64M	$451.64M	$451.64M	$451.64M	$500.61M	$500.61M	$500.61M	$500.61M	$546.24M	$569.07M	$544.46M	$519.41M	$574.82M	$642.10M	$627.46M	$604.29M	$667.51M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+10.8%	+0.0%	+0.0%	+0.0%	+9.1%	+4.2%	-4.3%	-4.6%	+10.7%	+11.7%	-2.3%	-3.7%	+10.5%
YoY Change	—	—	—	—	+10.8%	+10.8%	+10.8%	+10.8%	+9.1%	+13.7%	+8.8%	+3.8%	+5.2%	+12.8%	+15.2%	+16.3%	+16.1%

Range$451.64M – $667.51M

CAGR+10.3%

Avg YoY Growth+11.1%

Median YoY Growth+10.8%

Similar Metrics at Other Companies

Cisco Systems, Inc.CSCO View metric

CVS HealthCVS View metric

IntelINTC View metric

CVS HealthCVS View metric

Colgate-PalmoliveCL View metric

CarvanaCVNA View metric

Frequently Asked Questions

What is Idexx Laboratories's cag — gross profit?: Idexx Laboratories (IDXX) reported cag — gross profit of $667.51M in Q1 2026.
How has Idexx Laboratories's cag — gross profit changed year-over-year?: Idexx Laboratories's cag — gross profit increased by 16.1% year-over-year, from $574.82M to $667.51M.
What is the long-term trend for Idexx Laboratories's cag — gross profit?: Over 3 years (2022 to 2025), Idexx Laboratories's cag — gross profit has grown at a 10.7% compound annual growth rate (CAGR), from $1.81B to $2.45B.
What does cag — gross profit mean?: The profit remaining from companion animal segment sales after subtracting the direct costs of producing those goods and services.